Endocannabinoid
Resource Center
TOP ARTICLES
Cannabidiol May Reduce Intestinal Inflammation
In this study, published in PLOS ONE, researchers explored the role of cannabidiol for intestinal inflammation. This research looked enteric glial cells (EGC), which plays a fundamental role in the maintenance of gut homeostasis. They assure the correct trophism of vicinal neurons in the myenteric plexus and actively participate in
Understanding Cannabinoid Delivery Systems and Clinical Applications
There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The transformation of cannabinoids from herbal preparations into highly regulated prescription drugs is therefore progressingRead
The Endocannabinoid System and Potential Therapeutic Uses in Multiple Sclerosis and other Neuroinflammatory Diseases
Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous system, caused by an autoimmune response against myelin that eventually leads to progressive neurodegeneration and disability. Although the knowledge on its underlying neurobiological mechanisms has considerably improved, there is a still unmet need for new treatment options,Read
Is Cannabidiol the Next Clinical Antioxidant?
Emerging research shows that cannabidiol holds unique properties as an antioxidant. In the scientific summary, we profile two studies that review the potential of non-psychotropic cannabidiol as an antioxidant. This research has future clinical implications for cerebral ischemia, rheumatoid arthritis, types I and II diabetes, atherosclerosis, Alzheimer’s disease, hypertension, the
Effectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients
Approximately 25 percent of drug-resistant epilepsy patients taking cannabidiol (CBD) developed a tolerance to the treatment, researchers said at the American Epilepsy Society annual meeting taking place Nov.30 – Dec. 4, 2018. The findings suggest that that the effectiveness of the CBD drug might wane in the long term for
Derrick DeSilva, MD, on CBD for Common Conditions, Choosing a Safe, Reliable Brand
In this video, Dr. DeSilva shares some case studies and how he is prescribing CBD for common conditions for his patients. In this video series he discusses the following: Case studies of patient response to CBD for sleep and auto-immunity, Researching the right brand of CBD, What to look for
New Pathways Discovered for CBD’s Ability to Provide Pain and Anxiety Relief
While cannabidiol (CBD) is fast becoming a common compound for pain and anxiety relief, the exact pathways and dosage have remained elusive. A recent study, published in the journal PAIN, identified new pathways, beyond the endocannabinoid system, which explain its analgesic and anti-anxiety benefits. They are surprisingly different than what
